Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 2/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | BAD | Q92934 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728646 | 1.00 | KEAP1 (0.53) | KEAP1RXRBRXRACLCN2CES2 | |
| SCHEMBL2560228 | 0.84 | CES2 (0.50) | KEAP1CLCN2CES2CES1HPGD | |
| SCHEMBL14089891 | 0.84 | RXRB (0.61) | RXRBRXRANOTUMKDM4EBCL2L1 | |
| SCHEMBL25377745 | 0.83 | NR1H4 (0.43) | KEAP1RXRBRXRACLCN2KDM4E | |
| SCHEMBL836181 | 0.83 | CES2 (0.50) | KEAP1RXRBRXRACLCN2CES2 | |
| SCHEMBL30628278 | 0.83 | CES2 (0.48) | KEAP1CES2CES1ALDH1A1MEN1 | |
| SCHEMBL1121927 | 0.83 | CES2 (0.48) | KEAP1CES2CES1ALDH1A1MEN1 | |
| SCHEMBL29780492 | 0.83 | KEAP1 (0.59) | KEAP1CLCN2CES2CES1NOTUM | |
| SCHEMBL11476969 | 0.83 | CES2 (0.48) | KEAP1CLCN2CES2CES1MEN1 | |
| SCHEMBL145273 | 0.83 | KEAP1 (0.59) | KEAP1CLCN2CES2CES1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 787 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410106-B | Benzamide HBV capsid protein inhibitor and preparation method and application thereof | 山东第二医科大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-116998480-A | Suspension containing fluazinam and preparation method thereof | 江苏禾裕泰化学有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-116410106-A | Benzamide HBV capsid protein inhibitor and preparation method and application thereof | 潍坊医学院 | 2023-07-11 | — | — | CN | claimed |
| CN-112209876-B | Preparation method of 3-trifluoromethyl isoquinolinone derivative | 华侨大学 | 2022-08-26 | — | — | CN | claimed |
| EP-3551633-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2021-03-31 | — | — | EP | claimed |
| CN-112209876-A | Preparation method of 3-trifluoromethyl isoquinolinone derivative | 华侨大学 | 2021-01-12 | — | — | CN | claimed |
| CN-110903182-A | Simple and environment-friendly chemical synthesis method of 4-fluoro-2-methylbenzoic acid | 北京艾德旺科技发展有限公司 | 2020-03-24 | — | — | CN | claimed |
| CN-110903176-A | Chemical synthesis method of 4-fluoro-2-methylbenzoic acid | 北京艾德旺科技发展有限公司 | 2020-03-24 | — | — | CN | claimed |
| EP-2516479-B1 | NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS | BASF CORP (US) | 2016-04-20 | — | — | EP | claimed |
| EP-2516479-A2 | NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS | BASF Corporation (US) | 2012-10-31 | — | — | EP | claimed |
| US-8211819-B2 | Internal and external donor compounds for olefin polymerization catalysts | BASF CORPORATION (US) | 2012-07-03 | — | — | US | claimed |
| WO-2011084691-A2 | NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS | BASF CORPORATION (US) | 2011-07-14 | — | — | WO | claimed |
| US-20110152481-A1 | Internal and external donor compounds for olefin polymerization catalysts | BASF CATALYSTS LLC (US) | 2011-06-23 | — | — | US | claimed |
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | AVENTIS PHARMA S.A. (FR) | 2005-08-04 | — | — | US | claimed |
| EP-0069598-B1 | PREPARATION OF AROMATIC KETONES | RAYCHEM CORPORATION (a California corporation) (US) | 1984-12-19 | — | — | EP | claimed |
| EP-3802500-B1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | CRINETICS PHARMACEUTICALS INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-4792618-A | CHEMICAL INTERMEDIATE FOR POLYMERS AND PESTICIDES | OCCIDENTAL CHEMICAL CORPORATION (US) | 1988-12-20 | — | — | US | disclosed |
| US-4016274-A | TRANQUILIZERS AND ANTICONVULSANT AGENTS | RHONE-POULENC S.A. (FR) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171346-A1 | Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation | HEXD, CDK5, CHUK | KEAP1 1682/4885RXRB 3152/4885RXRA 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.